rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2003-7-28
|
pubmed:abstractText |
The authors recently demonstrated that administration of the melanocortin-4 receptor antagonist SHU9119 decreased neuropathic pain symptoms in rats with a sciatic chronic constriction injury. The authors hypothesised that there is a balance between tonic pronociceptive effects of the spinal melanocortin system and tonic antinociceptive effects of the spinal opioid system. Therefore, they investigated a possible interaction between these two systems and tested whether opioid effectiveness could be increased through modulation of the spinal melanocortin system activity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Endorphins,
http://linkedlifedata.com/resource/pubmed/chemical/Melanocyte-Stimulating Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/Naloxone,
http://linkedlifedata.com/resource/pubmed/chemical/Narcotic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Melanocortin, Type 4,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Corticotropin,
http://linkedlifedata.com/resource/pubmed/chemical/SHU 9119,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-MSH,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-MSH (4-10)amide...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0003-3022
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
449-54
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12883419-Analgesics, Opioid,
pubmed-meshheading:12883419-Animals,
pubmed-meshheading:12883419-Drug Interactions,
pubmed-meshheading:12883419-Endorphins,
pubmed-meshheading:12883419-Male,
pubmed-meshheading:12883419-Melanocyte-Stimulating Hormones,
pubmed-meshheading:12883419-Morphine,
pubmed-meshheading:12883419-Naloxone,
pubmed-meshheading:12883419-Narcotic Antagonists,
pubmed-meshheading:12883419-Pain,
pubmed-meshheading:12883419-Physical Stimulation,
pubmed-meshheading:12883419-Rats,
pubmed-meshheading:12883419-Rats, Wistar,
pubmed-meshheading:12883419-Receptor, Melanocortin, Type 4,
pubmed-meshheading:12883419-Receptors, Corticotropin,
pubmed-meshheading:12883419-Sensory Thresholds,
pubmed-meshheading:12883419-Spinal Cord,
pubmed-meshheading:12883419-alpha-MSH
|
pubmed:year |
2003
|
pubmed:articleTitle |
Interaction between the spinal melanocortin and opioid systems in a rat model of neuropathic pain.
|
pubmed:affiliation |
Department of Medical Pharmacology and Anesthesiology, Rudolf Magnus Institute for Neurosciences, University Medical Center Utrecht, Utrecht, The Netherlands. d.h.vrinten@med.uu.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|